{
    "organizations": [],
    "uuid": "70c597bc565bed93c564fce7395077872985f941",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-edge-therapeutics-reports-qtrly-lo/brief-edge-therapeutics-reports-qtrly-loss-per-share-0-45-idUSASB0C88G",
    "ord_in_thread": 0,
    "title": "Edge Therapeutics Reports Qtrly Loss Per Share $0.45",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 1 (Reuters) - Edge Therapeutics Inc:\n* EDGE THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS\n* EDGE THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.45\n* EDGE THERAPEUTICS INC - SEES TOP-LINE RESULTS FROM FULL NEWTON 2 STUDY IN LATE 2018 Source text for Eikon: (Reuters.Brief@thomsonreuters.com)\n ",
    "published": "2018-03-01T19:36:00.000+02:00",
    "crawled": "2018-03-02T19:42:45.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "edge",
        "therapeutic",
        "inc",
        "edge",
        "therapeutic",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "edge",
        "therapeutic",
        "inc",
        "qtrly",
        "loss",
        "per",
        "share",
        "edge",
        "therapeutic",
        "inc",
        "see",
        "result",
        "full",
        "newton",
        "study",
        "late",
        "source",
        "text",
        "eikon"
    ]
}